In a regulatory filing, Perspective Therapeutics disclosed that its CEO Johan Spoor bought 100K shares of common stock on June 13th in a total transaction size of $117.4K. Shares of Perspective Therapeutics are up 8% afterhours at $1.25.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CATX:
- Perspective Therapeutics Announces Inclusion in the Russell 3000® Index
- Perspective Therapeutics announces inclusion in the Russell 3000 Index
- Perspective Therapeutics announces 1-for-10 reverse stock split
- Perspective Therapeutics Announces 1-for-10 Reverse Stock Split
- Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting